DJS Antibodies Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
18
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$287M
DJS Antibodies General Information
Description
Developer of novel therapeutic monoclonal antibodies designed to target G-protein-coupled receptors (GPCRs). The company specializes in the research and discovery of functional antibodies to complex protein targets that have been intractable to drug discovery in order to isolate high-quality antibodies against proteins, enabling physicians to treat currently undruggable and untreatable diseases.
Contact Information
Website
www.djsantibodies.com(Operating Subsidiary)
Corporate Office
- Cherwell Innovation Centre
- 77 Heyford Park, Upper Heyford, Oxfordshire
- Bicester OX25 5HD
- England, United Kingdom
Corporate Office
- Cherwell Innovation Centre
- 77 Heyford Park, Upper Heyford, Oxfordshire
- Bicester OX25 5HD
- England, United Kingdom
DJS Antibodies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Merger/Acquisition | 19-Oct-2022 | $287M | Completed | Generating Revenue | ||
| 10. Seed Round | 02-Feb-2022 | Completed | Generating Revenue | |||
| 9. Seed Round | 22-Dec-2020 | Completed | Generating Revenue | |||
| 8. Grant | 01-Jun-2020 | Completed | Pre-Clinical Trials | |||
| 7. Grant | 01-Apr-2019 | Completed | Pre-Clinical Trials | |||
| 6. Grant | 01-Dec-2017 | Completed | Pre-Clinical Trials | |||
| 5. Seed Round | 05-Oct-2016 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 04-Apr-2016 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 01-Jan-2016 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 01-Nov-2015 | $38.3K | Completed | Pre-Clinical Trials |
DJS Antibodies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference Shares | ||||||||
| Ordinary 1 |
DJS Antibodies Comparisons
Industry
Financing
Details
DJS Antibodies Competitors (11)
One of DJS Antibodies’s 11 competitors is Absolute Antibody, a Private Equity-Backed company based in Redcar, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Absolute Antibody | Private Equity-Backed | Redcar, United Kingdom | ||||
| Agrisera | Formerly PE-Backed | Vannas, Sweden | ||||
| Crescendo Biologics | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Integrated DNA Technologies | Formerly PE-Backed | Coralville, IA | ||||
| Personal Genome Diagnostics | Formerly VC-backed | Baltimore, MD |
DJS Antibodies Patents
DJS Antibodies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12599645-B2 | Antibodies which bind to lysophosphatidic acid receptor 1 (lpar1) | Active | 02-Sep-2021 | ||
| US-20260294999-A1 | Antibodies which bind to lysophosphatidic acid receptor 1 (lpar1) | Pending | 02-Sep-2021 | ||
| AU-2022338282-A1 | Polypeptides | Pending | 02-Sep-2021 | ||
| AU-2026226436-A1 | Polypeptides | Pending | 02-Sep-2021 | ||
| CA-3230808-A1 | Polypeptides | Pending | 02-Sep-2021 | C07K14/705 |
DJS Antibodies Signals
DJS Antibodies Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amgen Ventures | Corporate Venture Capital | Minority | ||
| Innovate UK | Government | |||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| LifeArc Ventures | Venture Capital | Minority | ||
| MassChallenge | Accelerator/Incubator | Minority |
DJS Antibodies FAQs
-
When was DJS Antibodies founded?
DJS Antibodies was founded in 2014.
-
Where is DJS Antibodies headquartered?
DJS Antibodies is headquartered in Bicester, United Kingdom.
-
What is the size of DJS Antibodies?
DJS Antibodies has 18 total employees.
-
What industry is DJS Antibodies in?
DJS Antibodies’s primary industry is Drug Discovery.
-
Is DJS Antibodies a private or public company?
DJS Antibodies is a Private company.
-
What is the current valuation of DJS Antibodies?
The current valuation of DJS Antibodies is .
-
What is DJS Antibodies’s current revenue?
The current revenue for DJS Antibodies is .
-
How much funding has DJS Antibodies raised over time?
DJS Antibodies has raised $17.5M.
-
Who are DJS Antibodies’s investors?
Amgen Ventures, Innovate UK, Johnson & Johnson JJDC, LifeArc Ventures, and MassChallenge are 5 of 9 investors who have invested in DJS Antibodies.
-
Who are DJS Antibodies’s competitors?
Absolute Antibody, Agrisera, Crescendo Biologics, Integrated DNA Technologies, and Personal Genome Diagnostics are some of the 11 competitors of DJS Antibodies.
-
When was DJS Antibodies acquired?
DJS Antibodies was acquired on 19-Oct-2022.
-
Who acquired DJS Antibodies?
DJS Antibodies was acquired by AbbVie.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process